ICPT logo

ICPT Working Capital

ICPT Annual Working Capital

$310.05 M
-$29.81 M-8.77%

31 December 2022

ICPT Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ICPT Quarterly Working Capital

$292.60 M
+$8.85 M+3.12%

30 September 2023

ICPT Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ICPT Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-8.8%-9.6%
3 y3 years-44.6%-26.5%
5 y5 years-9.9%-33.6%

ICPT Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-50.7%-60.5%

Intercept Pharmaceuticals Working Capital History

DateAnnualQuarterly
Sept 2023
-
$292.60 M(+3.1%)
June 2023
-
$283.75 M(+0.1%)
Mar 2023
-
$283.34 M(-8.6%)
Dec 2022
$310.05 M(-8.8%)
$310.05 M(-4.2%)
Sept 2022
-
$323.79 M(-3.5%)
June 2022
-
$335.59 M(+2.8%)
Mar 2022
-
$326.32 M(-4.0%)
Dec 2021
$339.86 M(-7.3%)
$339.86 M(-3.6%)
Sept 2021
-
$352.48 M(+1.3%)
June 2021
-
$347.82 M(+1.9%)
Mar 2021
-
$341.33 M(-6.9%)
Dec 2020
$366.67 M(-34.4%)
$366.67 M(-7.9%)
Sept 2020
-
$397.97 M(-10.2%)
June 2020
-
$443.12 M(-7.3%)
Mar 2020
-
$478.22 M(-14.5%)
Dec 2019
$559.31 M(+51.9%)
$559.31 M(-11.1%)
Sept 2019
-
$629.11 M(-9.3%)
June 2019
-
$693.96 M(+135.7%)
Mar 2019
-
$294.46 M(-20.0%)
Dec 2018
$368.22 M(+7.0%)
$368.22 M(-16.4%)
Sept 2018
-
$440.50 M(-9.9%)
June 2018
-
$489.04 M(+72.0%)
Mar 2018
-
$284.40 M(-17.4%)
DateAnnualQuarterly
Dec 2017
$344.27 M(-45.3%)
$344.27 M(-20.7%)
Sept 2017
-
$433.93 M(-11.6%)
June 2017
-
$490.99 M(-12.7%)
Mar 2017
-
$562.31 M(-10.7%)
Dec 2016
$629.35 M(+5.9%)
$629.35 M(-15.0%)
Sept 2016
-
$740.05 M(+83.6%)
June 2016
-
$403.11 M(-15.3%)
Mar 2016
-
$475.69 M(-20.0%)
Dec 2015
$594.32 M(+157.7%)
$594.32 M(-11.3%)
Sept 2015
-
$670.36 M(-6.5%)
June 2015
-
$717.17 M(+82.8%)
Mar 2015
-
$392.23 M(+70.1%)
Dec 2014
$230.59 M(+66.3%)
$230.59 M(-12.2%)
Sept 2014
-
$262.59 M(-10.9%)
June 2014
-
$294.73 M(-298.8%)
Mar 2014
-
-$148.22 M(-206.9%)
Dec 2013
$138.68 M(+40.3%)
$138.68 M(-8.1%)
Sept 2013
-
$150.84 M(-3.5%)
June 2013
-
$156.30 M(+62.5%)
Mar 2013
-
$96.16 M(-2.7%)
Dec 2012
$98.81 M(+564.4%)
$98.81 M(+207.8%)
Sept 2012
-
$32.11 M(-10.6%)
June 2012
-
$35.90 M(+141.4%)
Dec 2011
$14.87 M
$14.87 M

FAQ

  • What is Intercept Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals annual working capital year-on-year change?
  • What is Intercept Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals quarterly working capital year-on-year change?

What is Intercept Pharmaceuticals annual working capital?

The current annual working capital of ICPT is $310.05 M

What is the all time high annual working capital for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high annual working capital is $629.35 M

What is Intercept Pharmaceuticals annual working capital year-on-year change?

Over the past year, ICPT annual working capital has changed by -$29.81 M (-8.77%)

What is Intercept Pharmaceuticals quarterly working capital?

The current quarterly working capital of ICPT is $292.60 M

What is the all time high quarterly working capital for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high quarterly working capital is $740.05 M

What is Intercept Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, ICPT quarterly working capital has changed by -$31.19 M (-9.63%)